Gencurix Faces Kosdaq Listing Review, Potential Delisting
The exchange designated Gencurix for a Kosdaq listing eligibility review, which could lead to delisting.
Related stories
Gencurix Trading Halt Extended Pending Delisting Review Decision
Trading in Gencurix common shares on the KOSDAQ has been extended until a decision is made on whether grounds for delisting apply.
L impact | REGULATION | Nov 02, 2026, 09:34 AM UTC
Handal Energy Faces Bursa Delisting Over Overdue 2025 Annual Report
Handal Energy faces potential delisting from Bursa over its overdue 2025 annual report.
M impact | REGULATION | Nov 02, 2026, 09:25 AM UTC
Belgian Prime Minister Bart De Wever Submits Resignation to King
Reuters reports that Belgian Prime Minister Bart De Wever submitted his resignation to the king.
M impact | REGULATION | Nov 02, 2026, 09:23 AM UTC
FDA Approves Inovio Treatment; Shares More Than Triple Premarket
The FDA approved an Inovio treatment for a rare respiratory condition. Inovio shares more than tripled premarket.
M impact | REGULATION | Nov 02, 2026, 09:14 AM UTC
China Central Bank Uses Liquidity Tool to Fund Share Purchases
M impact | REGULATION | Nov 02, 2026, 09:12 AM UTC
South Korea Finalizes Fine Against Broadcom
South Korea finalized a fine against Broadcom over its component dealings with Samsung.
M impact | REGULATION | Nov 02, 2026, 09:08 AM UTC